Sanders wants to replace patents with prizes for drug inventions

SenatehealthcommitteeChairBernieSanders(I-Vt.)wantstorewardnewmedicineswithprizemoney.JoseLuisMagana AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration




hotspot

author：Wikipedia    Page View：75469
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services
Next article： What does generative AI mean for health care? We asked experts